๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A phase II trial of tamoxifen in hepatocellular carcinoma

โœ Scribed by Paul F. Engstrom; Bernard Levin; Charles G. Moertel; Allan Schutt

Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
224 KB
Volume
65
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A Phase II trial of nolatrexed dihydroch
A Phase II trial of nolatrexed dihydrochloride in patients with advanced hepatocellular carcinoma
โœ Keith Stuart; Judy Tessitore; Jeff Rudy; Neil Clendennin; Amanda Johnston ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 70 KB ๐Ÿ‘ 2 views

## BACKGROUND. Inoperable hepatocellular carcinoma is an incurable malignancy with no accepted standard therapy. Chemotherapy has demonstrated occasional responses and the need is great for a new and effective agent. Therefore the authors conducted this Phase II trial of a novel thymidylate syntha

Phase II study of flutamide in the treat
Phase II study of flutamide in the treatment of hepatocellular carcinoma
โœ Yee Chao; Wing-Kai Chan; Yi-Shin Huang; Ho-Chung Teng; Sun-Sang Wang; Wing-Yiu L ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 408 KB ๐Ÿ‘ 2 views

## BACKGROUND. Hepatocellular carcinoma (HCC) is a male predominant disease and may be an androgen-dependent or androgen-responsive tumor. This Phase I1 study was designed to investigate the clinical activity and toxicity of flutamide in the treatment of patients with advanced HCC. METHODS. Thirty